Sanofi partners with Snowflake to build AI agent for sales teams
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Oil market losses easing as nearly 80% of disrupted supply returns, UBS says
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Sanofi Chooses Snowflake to Accelerate its AI-Powered Drug Development
June 2, 2026 9:08 AM EDTSanofi is reinventing drug development on Snowflake, bringing AI directly to its data with the goal of becoming the first biopharma company powered by AI at scale
New Blueprint for Biopharma: Sanofi moves to a unified, AI-ready foundation that powers faster decisions across R&D, manufacturing, and commercial AI Replacing Applications: Snowflake Cortex AI, including Snowflake CoWork and AI workflow partner Elementum, power AI directly on Sanofi's data Proven in the Field: Sanofi's new "Concierge for Field" agent equips sales reps with AI-generated pre-call plans in... More